Related Experiment Video
Updated: May 7, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Oral Citrate Supplementation Mitigates Age-Associated Pathologic Intervertebral Disc Calcification in LG/J Mice
Olivia K Ottone1,2, Jorge J Mundo1, Boahen N Kwakye1
1Department of Orthopaedic Surgery, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Oral potassium citrate (K3Citrate) supplementation effectively reduced age-associated intervertebral disc calcification in mice. This treatment offers a potential systemic strategy for managing this common condition without adverse effects on bone or locomotion.
Area of Science:
- Biomedical research
- Skeletal biology
- Pharmacology
Background:
- Age-dependent intervertebral disc calcification is prevalent and lacks effective treatments.
- LG/J mice exhibit spontaneous, age-associated disc calcification, serving as a relevant model.
- Understanding the mechanisms of disc calcification is crucial for developing therapeutic interventions.
Purpose of the Study:
- To evaluate the efficacy of long-term oral potassium citrate (K3Citrate) supplementation in ameliorating intervertebral disc calcification in LG/J mice.
- To investigate the impact of K3Citrate on vertebral bone structure, knee calcification, plasma chemistry, and locomotion.
- To elucidate the mechanistic effects of K3Citrate on cellular differentiation and mineral composition within the intervertebral disc.
Main Methods:
- Long-term oral administration of K3Citrate to LG/J mice.
- Assessment of disc calcification incidence and severity.
- Analysis of vertebral bone structure, knee calcification, plasma chemistry, and locomotion.
- Fourier-transform infrared (FTIR) spectroscopy to analyze mineral composition.
- Evaluation of endochondral differentiation in nucleus pulposus (NP) and endplate cells.
Main Results:
- K3Citrate significantly reduced the incidence of intervertebral disc calcification.
- No adverse effects were observed on vertebral bone structure, knee calcification, plasma chemistry, or general locomotion.
- Treated mice showed improved grip strength.
- FTIR analysis confirmed K3Citrate did not alter the mineral composition of calcified nodules.
- K3Citrate mitigated calcification by chelating Ca2+ and differentially affected cell differentiation, reducing hypertrophic chondrocytic fate in NP cells but not impacting endplates.
Conclusions:
- Oral K3Citrate is a promising systemic intervention for age-dependent intervertebral disc calcification.
- The therapeutic effect involves Ca2+ chelation and modulation of NP cell differentiation.
- K3Citrate ameliorates disc calcification without compromising skeletal integrity or general physical function.
More Related Videos
Related Concept Videos
Degenerative Disc Disease I: Introduction
Degenerative Disc Disease ll: Pathophysiology

